{"adverse_reactions":["6 ADVERSE REACTIONS The most common side effects associated with antihistamines include drowsiness, sedation, dryness of mucous membranes, and gastrointestinal effects. Serious side effects with oral antihistamines or sympathomimetics have been rare. Other reactions may include: Dermatologic: urticaria, drug rash, photosensitivity, pruritus Cardiovascular: hypotension, hypertension, cardiac arrhythmias, palpitations Central Nervous System (CNS): disturbed coordination, tremor, irritability, insomnia, visual disturbances, weakness, nervousness, convulsion, headache, euphoria, and dysphoria Genitourinary: urinary frequency, difficult urination Gastrointestinal: epigastric discomfort, anorexia, nausea, vomiting, diarrhea, constipation Respiratory: tightness of chest and wheezing, shortness of breath Hematologic: hemolytic anemia, thrombocytopenia, agranulocytosis To report SUSPECTED ADVERSE REACTIONS, contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch."],"clinical_pharmacology":["12 CLINICAL PHARMACOLOGY Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension combines the antihistaminic action of pyrilamine with the sympathomimetic decongestant effect of phenylephrine. 12.1 Mechanism of Action Pyrilamine maleate Pyrilamine maleate is an antihistamine, H1 receptor blocking agent belonging to the ethylenediamine class of antihistamines. H1-blocking drugs inhibit the actions of histamine on smooth muscle, capillary permeability, and can both stimulate and depress the central nervous system. Pyrilamine also possesses anticholinergic and sedative properties. Phenylephrine HCl Phenylephrine hydrochloride is a decongestant which is a potent postsynaptic α-receptor agonist with little effect on β receptors of the heart. A direct action at receptors accounts for the greater part of its effects, only a small part being due to its ability to release norepinephrine. Phenylephrine has no effect on β-adrenergic receptors of the bronchi or peripheral blood vessels."],"contraindications":["4 CONTRAINDICATIONS Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension is contraindicated in patients with a known sensitivity to any of its components. It is also contraindicated in patients with severe hypertension or peripheral vascular insufficiency, as ischemia may result, with the risk of gangrene or thrombosis of compromised vascular beds. Antihistamines are contraindicated for use in the treatment of lower respiratory tract conditions, including asthma. Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension should not be used in patients receiving a monoamine oxidase (MAO) inhibitor."],"description":["11 DESCRIPTION Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension is a grape-flavored, dye-free, combination antihistamine/nasal decongestant suspension. Each 5 mL (one teaspoonful) for oral administration contains: Pyrilamine maleate.....................................16 mg Phenylephrine hydrochloride ........................5 mg Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension also contains: citric acid, glycerin, grape flavor, methylparaben, purified water, sodium saccharin, benzoic acid, sodium citrate, xanthan gum, propylene glycol, and propylparaben. Pyrilamine Maleate is an antihistamine having the chemical name, 1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N', N'-dimethyl-N-2-pyridinyl-, (Z)-2-butenedioate (1:1). Phenylephrine hydrochloride is an orally effective nasal decongestant. Chemically it is (–)-m-Hydroxy-_- [(methylamino)methyl]benzyl alcohol hydrochloride."],"dosage_and_administration":["2 DOSAGE AND ADMINISTRATION RECOMMENDED DOSES MAY BE ADMINISTERED EVERY 6 HOURS. Adults and children 12 years of age and older: 5-10 mL (1-2 teaspoonfuls). (2) Children 6-12 years of age: 5 mL (1 teaspoonful). (2) Children 2-6 years of age: 2.5 mL (1/2 teaspoonful). (2) Under 2 years of age: Consult a physician. (2)"],"dosage_forms_and_strengths":["3 DOSAGE FORM AND STRENGTH Oral suspension, pyrilamine maleate 16 mg, phenylephrine hydrochloride 5 mg per 5 mL"],"drug_interactions":["7 DRUG INTERACTIONS MAO inhibitors may prolong and intensify the anticholinergic effects of antihistamines and the overall effects of sympathomimetic agents; therefore, concomitant administration of Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension and MAO inhibitors should be avoided (see 4 CONTRAINDICATIONS )."],"effective_time":"20101211","how_supplied":["16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension is a grape-flavored, dye-free suspension supplied in 16 oz. (473 mL) bottles, NDC 68032-439-16. 16.2 Storage and Handling KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. Store at controlled room temperature 20°-25°C (68°-77°F) PHARMACIST: Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure."],"id":"c7d6aace-3ea5-4da6-a72d-2e82c9ec4b3c","indications_and_usage":["1 INDICATIONS AND USAGE Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension is indicated for temporary relief of the swelling and nasal congestion associated with the common cold, sinusitis, allergic rhinitis, and other upper respiratory conditions. Appropriate therapy should be provided for the primary disease."],"information_for_patients":["17 PATIENT COUNSELING INFORMATION Patients receiving Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension should be given the following information: 1. Do not drink alcoholic beverages or engage in potentially hazardous activities requiring alertness, such as driving a car or operating machinery, while using this drug. 2. Do not take this product if currently taking a prescription MAO inhibitor (for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAO inhibitor. Instruct patients to consult a health professional if they are unsure whether a prescription drug contains an MAO inhibitor before taking Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension . *Sections or subsections omitted from the full prescribing information are not listed. Manufactured for: River’s Edge Pharmaceuticals, LLC. Suwanee, GA 30024 Rev. 02/10 439-10"],"openfda":{},"overdosage":["10 OVERDOSAGE: 10.1 Signs and Symptoms These may vary from CNS depression to stimulation (restlessness to convulsions). Antihistamine overdosage in young children may lead to convulsions and death. Atropine-like signs and symptoms may be prominent. 10.2 Treatment Induce vomiting if it has not occurred spontaneously. Precautions must be taken against aspiration, especially in infants, children, and comatose patients. If gastric lavage is indicated, isotonic or half-isotonic saline solution is preferred. Stimulants should not be used. If hypotension is a problem, vasopressor agents may be considered."],"package_label_principal_display_panel":["PACKAGING Below represents the current packaging being used: NDC 68032-439-16 Pyril Mal 16mg/ Phenyleph HCl 5 mg/ 5mL Suspension Rx Only Pyrlamine maleate 16 mg/5 mL Phenylephrine hydrochloride 5 mg/5 mL Grape Flavor EACH TEASPOONFUL (5 mL) CONTAINS: Pyrlamine maleate .................. 16 mg Phenylephrine HCl ..................... 5 mg 16 fl oz (473 mL) Indications: Pyril Mal 16 mg/Phenyleph HCl 5 mg/5 mL Suspension is indicated for temporary relief of the swelling and nasal congestion associated with the common cold, sinusitis, allergic rhinitis, and other upper respiratory conditions. Appropriate therapy should be provided for the primary disease. RECOMMENDED DOSES MAY BE ADMINISTERED EVERY 6 HOURS. Adults and children 12 years of age and older: 5-10 mL (1-2 teaspoonfuls). Children 6-12 years of age: 5 mL (1 teaspoonful). Children 2-6 years of age: 2.5 mL (1/2 teaspoonful). Under 2 years of age: Consult a physician. See package insert for dosing information and directions for use. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. Store at controlled room temperature 20°-25°C (68°-77°F) PHARMACIST: Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure. Manufactured for: River’s Edge Pharmaceuticals, LLC. Suwanee, GA 30024 Rev. 02/10 439-20 label"],"set_id":"b33c897c-4fbf-46de-bbad-7b238d7ff344","spl_product_data_elements":["Pyril Mal Phenyl HCl PYRILAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE PYRILAMINE MALEATE PYRILAMINE PHENYLEPHRINE HYDROCHLORIDE PHENYLEPHRINE CITRIC ACID MONOHYDRATE GLYCERIN METHYLPARABEN WATER SACCHARIN SODIUM BENZOIC ACID SODIUM CITRATE XANTHAN GUM PROPYLENE GLYCOL PROPYLPARABEN"],"use_in_specific_populations":["8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy Teratogenic Effects: Pregnancy Category C : Animal reproduction studies have not been conducted with Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension . It is not known whether this product can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension should be given to a pregnant woman only if clearly needed. 8.2 Labor and Delivery Administration of phenylephrine in late pregnancy or labor may cause fetal anoxia or bradycardia by increasing contractility of the uterus and decreasing uterine blood flow. 8.3 Nursing Mothers Because of the higher risk of intolerance of antihistamines in small infants generally, and in newborns and prematures in particular, Pyril Mal 16 mg/Phenyl HCl 5 mg/5 mL Suspension should not be administered to a nursing mother."],"version":"2","warnings_and_cautions":["5 WARNINGS AND PRECAUTIONS 5.1 General Antihistamines may cause drowsiness and may have additive CNS effects with alcohol or other CNS depressants such as hypnotics, sedatives, and tranquilizers. 5.2 Special Risk Patients Use with caution in patients with diabetes, hypertension, or cardiovascular disease, hyperthyroidism, narrow angle glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, and urinary bladder obstruction due to symptomatic prostatic hypertrophy and narrowing of the bladder neck. Antihistamines may cause excitability, particularly in pediatric patients, but their combination with sympathomimetics may cause either mild stimulation or mild sedation. Antihistamines are more likely to cause dizziness, sedation, and hypotension in elderly patients and should be prescribed with caution."]}